Hap Trading, LLC Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $2.1 Million - $3.68 Million	-25,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$110.08 - $142.92 $704,512 - $914,687	6,400 Added 34.04%	25,200 $115,000
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $1.87 Million - $2.79 Million	18,800 New	18,800 $56,000
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $10.1 Million - $14.4 Million	-157,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $6.07 Million - $9.17 Million	93,300 Added 146.24%	157,100 $690,000
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $51,727 - $87,113	1,300 Added 2.08%	63,800 $7,000
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $2.16 Million - $3.33 Million	62,500 New	62,500 $22,000
Q2 2018 Aug 13, 2018	SELL	$23.62 - $42.29 $710,962 - $1.27 Million	-30,100 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $676,949 - $1.04 Million	30,100 New	30,100 $23,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.